LACOSAMIDE
LACOSAMIDE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: LACOSAMIDE; Generic name: LACOSAMIDE; Manufacturer: Virtus Pharmaceuticals, LLC.
| Brand name | LACOSAMIDE |
|---|---|
| Generic name | LACOSAMIDE |
| Manufacturer | Virtus Pharmaceuticals, LLC |
| Used for | 1 INDICATIONS AND USAGE Lacosamide injection is indicated for: Treatment of partial-onset seizures in patients 17 years of age and older ( 1.1 ) 1.1 Partial-Onset Seizures Lacosamide injection is indicated for the treatment of partial-onset seizures in patients 17 years of age and older. Pediatric use information is approved for UCB, Inc.’s VIMPAT ® (lacosamide) injection. However, due to UCB, Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. |
| Dosage | 2 DOSAGE AND ADMINISTRATION Adults (17 years and older): Initial dosage for monotherapy for the treatment of partial-onset seizures is 100 mg twice daily ( 2.1 ) Initial dosage for adjunctive therapy for the treatment of partial-onset seizures is 50 mg twice daily ( 2.1 ) Maximum recommended dosage for monotherapy and adjunctive therapy is 200 mg twice daily ( 2.1 ) Increase dosage based on clinical response and tolerability, no more frequently than once per week ( 2.1 ) Injection: for intraveno |
| Active ingredient(s) | LACOSAMIDE |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01162e2f-967b-4596-8188-c0d9889c3814 |